India’s new drug pricing policy : will data be the stumbling block?

On December 7, India’s National Pharmaceutical Pricing Policy 2012 was finally tabled in Parliament. Assuming that this policy does get rolled out irrespective of a Supreme Court hearing on drug pricing playing out in parallel, the cornerstone of the policy i.e.data may create some vexing issues. Continue reading “India’s new drug pricing policy : will data be the stumbling block?”

India & drug pricing : Can key word in policy influence impact?

Could a single word in the new drug pricing policy mitigate the extent of its impact on the pharma industry’s profitability or is this mere wishful thinking?  A senior industry source claimed to Apothecurry that the choice of Continue reading “India & drug pricing : Can key word in policy influence impact?”